Track topics on Twitter Track topics that are important to you
MissionTo be a leader in the application of genome-based information and technologies for the improved diagnosis and treatment of major human diseases.
SignalGene Inc. is a Montreal-based, publicly traded company (SGI: Montreal and Toronto Stock Exchange) dedicated to improving human health care through the application of scientific breakthroughs in human genetic research.
Created in 1996 as Algène Biotechnologies Corporation, SignalGene is strengthening its position by combining the expertise of research collaborators with enabling technologies, management depth and commercial focus. The Company pursues human genomics research for the development of high value products and services that lead to major improvement in the practice of medicine.
SignalGene’s research activities focus on the identification of human genes and genes variants, which predict individual susceptibility to diseases and response to therapeutic drugs. This research also identifies novel targets for drug discovery.
Current research programs focus on five important human disorders, namely osteoporosis, breast cancer, psoriasis, obesity and Alzheimer’s disease; and involve collaborations with leading biomedical and clinical scientists in Quebec university hospitals.
The Company’s drug discovery strategy is based on a portfolio of proprietary nuclear receptor variants that are validated as potential drug targets for major human diseases.
Strategies for Sustainable Growth and Value Generation
To achieve its corporate objectives, SignalGene works with strategic partners to accelerate its own internal discovery programs and to generate revenue through license fees, milestone payments and future royalties. SignalGene also leverages its technologies and expertise to perform contract research to support its clients’ discovery programs.
SignalGene aims to generate a strong expanding revenue stream by the marketing of genotyping services with a special focus on pharmacogenomics and genetic profiling assays.
Its evolving portfolio of proprietary genetic markers and drug targets for major human diseases is the foundation of SignalGene’s ultimate objective, which is to develop and market diagnostic and therapeutic products.
SignalGene offers pharmaceutical and biotech companies a broad range of services.
Integrated Genomics Platforms
? Clinical cohorts: ethical recruitment of patients and collection of genomic samples and clinical data
? Gene discovery: positional cloning, allele association
? Target validation: transgenic mice models, functional assays
? Bioinformatics: database mining, statistical data analysis
? Pharmacogenomics markers: e.g. DMEs, APOE4, etc.
? Disease markers: genetic profiling, susceptibility testing
? Custom genotyping
SignalGene exploits a robust high throughput technology platform in a quality-controlled environment that, as of the year 2000 meets GLP/GMP standards.
Our discovery programs lead to major breakthroughs in the identification of genetic markers of disease susceptibility and response to drug therapy, and provide novel targets for new drug development.
8475 Christophe-Colomb Avenue Suite 1000
Phone: 514 850 2400
Fax: 514 850 2424
MENLO PARK, CA -- (Marketwired) -- 05/04/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre...
LIVINGSTON, NJ --(Marketwired - September 14, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a medical company that develops and commercializes a growing portfolio of propri...
Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...
MissionTo be a leader in the application of genome-based information and technologies for the improved diagnosis and treatment of major human diseases.Corporate ProfileSignalGene Inc. is a Montreal-ba...
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...
Founded in 2008 by the Axis Biotec Brasilâ¢ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....
COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...
Founded by Conrad Kenley in 1990, LCG, Inc. is a leader in providing grants management solutions to health and social services agencies. LCG Systems (a subsidiary of LCG, Inc.) ...
We have published hundreds of SignalGene Incorporated news stories on BioPortfolio along with dozens of SignalGene Incorporated Clinical Trials and PubMed Articles about SignalGene Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SignalGene Incorporated Companies in our database. You can also find out about relevant SignalGene Incorporated Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...